A Pourtier-Manzanedo

995 total citations
10 papers, 827 citations indexed

About

A Pourtier-Manzanedo is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, A Pourtier-Manzanedo has authored 10 papers receiving a total of 827 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Oncology and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in A Pourtier-Manzanedo's work include Drug Transport and Resistance Mechanisms (5 papers), Cancer therapeutics and mechanisms (3 papers) and Amino Acid Enzymes and Metabolism (2 papers). A Pourtier-Manzanedo is often cited by papers focused on Drug Transport and Resistance Mechanisms (5 papers), Cancer therapeutics and mechanisms (3 papers) and Amino Acid Enzymes and Metabolism (2 papers). A Pourtier-Manzanedo collaborates with scholars based in France, Switzerland and United Kingdom. A Pourtier-Manzanedo's co-authors include David Bernard, David Beach, Jesús Gil, Francis Loor, D Boesch, B Jachez, Claire Gavériaux‐Ruff, Pietro Bollinger, Inka Leier and Karin Barnouin and has published in prestigious journals such as Journal of Clinical Investigation, Oncogene and British Journal of Cancer.

In The Last Decade

A Pourtier-Manzanedo

10 papers receiving 806 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A Pourtier-Manzanedo France 8 475 437 183 145 108 10 827
Kenneth Steadman United States 16 611 1.3× 543 1.2× 160 0.9× 174 1.2× 101 0.9× 28 1.1k
Akiko Tohgo Japan 18 526 1.1× 501 1.1× 83 0.5× 87 0.6× 98 0.9× 37 930
Seiji Doi Japan 12 511 1.1× 365 0.8× 177 1.0× 78 0.5× 58 0.5× 20 737
S. Percy Ivy United States 13 527 1.1× 452 1.0× 50 0.3× 107 0.7× 46 0.4× 18 868
Lee R. Tanzer United States 14 464 1.0× 473 1.1× 62 0.3× 40 0.3× 86 0.8× 21 856
Eiji Hinoshita Japan 9 514 1.1× 276 0.6× 61 0.3× 142 1.0× 56 0.5× 11 709
Leah C. Young Canada 17 551 1.2× 986 2.3× 119 0.7× 72 0.5× 177 1.6× 26 1.3k
Ronald Drengler United States 13 487 1.0× 296 0.7× 104 0.6× 68 0.5× 70 0.6× 27 701
Anouk B. Schroeijers Netherlands 10 754 1.6× 405 0.9× 46 0.3× 254 1.8× 57 0.5× 10 979
Margaretha van der Deen Netherlands 12 384 0.8× 443 1.0× 187 1.0× 61 0.4× 125 1.2× 19 825

Countries citing papers authored by A Pourtier-Manzanedo

Since Specialization
Citations

This map shows the geographic impact of A Pourtier-Manzanedo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Pourtier-Manzanedo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Pourtier-Manzanedo more than expected).

Fields of papers citing papers by A Pourtier-Manzanedo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A Pourtier-Manzanedo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Pourtier-Manzanedo. The network helps show where A Pourtier-Manzanedo may publish in the future.

Co-authorship network of co-authors of A Pourtier-Manzanedo

This figure shows the co-authorship network connecting the top 25 collaborators of A Pourtier-Manzanedo. A scholar is included among the top collaborators of A Pourtier-Manzanedo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A Pourtier-Manzanedo. A Pourtier-Manzanedo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Bernard, David, A Pourtier-Manzanedo, Jesús Gil, & David Beach. (2003). Myc confers androgen-independent prostate cancer cell growth. Journal of Clinical Investigation. 112(11). 1724–1731. 151 indexed citations
2.
Pourtier-Manzanedo, A, Chantal Vercamer, Éric Van Belle, et al.. (2003). Expression of an Ets-1 dominant-negative mutant perturbs normal and tumor angiogenesis in a mouse ear model. Oncogene. 22(12). 1795–1806. 43 indexed citations
3.
Bernard, David, A Pourtier-Manzanedo, Jesús Gil, & David Beach. (2003). Myc confers androgen-independent prostate cancer cell growth. Journal of Clinical Investigation. 112(11). 1724–1731. 152 indexed citations
4.
Barnouin, Karin, Inka Leier, Gabriele Jedlitschky, et al.. (1998). Multidrug resistance protein-mediated transport of chlorambucil and melphalan conjugated to glutathione. British Journal of Cancer. 77(2). 201–209. 76 indexed citations
5.
Pourtier-Manzanedo, A, Agnès Didier, Sylvie Froidevaux, & Francis Loor. (1995). Lymphotoxicity and myelotoxicity of doxorubicin and SDZ PSC 833 combined chemotherapies for normal mice. Toxicology. 99(3). 207–217. 11 indexed citations
6.
7.
Pourtier-Manzanedo, A, Agnès Didier, Christian D. Muller, & Francis Loor. (1992). SDZ PSC 833 and SDZ 280–446 are the most active of various resistance-modifying agents in restoring rhodamine-123 retention within multidrug resistant P388 cells. Anti-Cancer Drugs. 3(4). 419–426. 18 indexed citations
8.
Pourtier-Manzanedo, A, Andrea Didier, & Francis Loor. (1992). Expression of P-glycoprotein on normal lymphocytes: enhancement of the doxorubicin-sensitivity of concanavalin A-responding mouse spleen cells by P-glycoprotein blockers.. PubMed. 4(11-12). 473–80. 6 indexed citations
9.
Boesch, D, Claire Gavériaux‐Ruff, B Jachez, et al.. (1991). In vivo circumvention of P-glycoprotein-mediated multidrug resistance of tumor cells with SDZ PSC 833.. PubMed. 51(16). 4226–33. 322 indexed citations
10.
Pourtier-Manzanedo, A, et al.. (1991). FK-506 (fujimycin) reverses the multidrug resistance of tumor cells in vitro. Anti-Cancer Drugs. 2(3). 279–284. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kenneth Steadman Breakdown of academic impact, for papers by Akiko Tohgo Breakdown of academic impact, for papers by Seiji Doi Breakdown of academic impact, for papers by S. Percy Ivy Breakdown of academic impact, for papers by Lee R. Tanzer Breakdown of academic impact, for papers by Eiji Hinoshita Breakdown of academic impact, for papers by Leah C. Young Breakdown of academic impact, for papers by Ronald Drengler Breakdown of academic impact, for papers by Anouk B. Schroeijers Breakdown of academic impact, for papers by Margaretha van der Deen
Rankless by CCL
2026